Daniel T. Leung, MD; Regina C. LaRocque, MD; Edward T. Ryan, MD
CME Objective: To review current evidence for precautions, prophylaxis, treatment, diagnosis, and practice improvement of travel medicine.
Funding Source: American College of Physicians.
Disclosures: Dr. Ryan, ACP Contributing Author, reports grants from the Centers for Disease Control and Prevention during the conduct of the study. Drs. Leung and LaRocque, ACP Contributing Authors, have nothing to disclose. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-2481.
Acknowledgment: This work was supported by funding from the Centers for Disease Control and Prevention (U01CK000490).
With the assistance of additional physician writers, the editors of Annals of Internal Medicine develop In the Clinic using MKSAP and other resources of the American College of Physicians.
In the Clinic does not necessarily represent official ACP clinical policy. For ACP clinical guidelines, please go to https://www.acponline.org/clinical_information/guidelines/.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that she has no financial relationships or interests to disclose. Darren B. Taichman, MD, PhD, Executive Deputy Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Pfizer and Johnson & Johnson.
International travel can result in new illness or exacerbate existing conditions, and primary care clinicians have the opportunity to provide both pre- and posttravel health care. Providers should be familiar with destination-specific disease risks, be knowledgeable about travel and routine vaccines, be prepared to prescribe chemoprophylaxis and self-treatment regimens, and be aware of travel medicine resources.
Leung DT, LaRocque RC, Ryan ET. Travel Medicine. Ann Intern Med. 2018;168:ITC1–ITC16. doi: 10.7326/AITC201801020
Download citation file:
Published: Ann Intern Med. 2018;168(1):ITC1-ITC16.
Emergency Medicine, Infectious Disease, Prevention/Screening, Vaccines/Immunization.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use